ELEV
Wells Fargo’s Elevation Oncology ELEV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $163 | Sell |
444
-29,235
| -99% | -$10.7K | ﹤0.01% | 5989 |
|
|
2025
Q1 | $7.69K | Buy |
29,679
+654
| +2% | +$169 | ﹤0.01% | 5476 |
|
|
2024
Q4 | $16.3K | Buy |
29,025
+9,859
| +51% | +$5.55K | ﹤0.01% | 5315 |
|
|
2024
Q3 | $11.5K | Buy |
19,166
+20
| +0.1% | +$12 | ﹤0.01% | 5359 |
|
|
2024
Q2 | $51.7K | Buy |
19,146
+18,901
| +7,715% | +$51K | ﹤0.01% | 4915 |
|
|
2024
Q1 | $1.26K | Buy |
245
+4
| +2% | +$21 | ﹤0.01% | 5708 |
|
|
2023
Q4 | $129 | Buy |
241
+12
| +5% | +$6 | ﹤0.01% | 6263 |
|
|
2023
Q3 | $152 | Buy |
229
+131
| +134% | +$87 | ﹤0.01% | 6271 |
|
|
2023
Q2 | $149 | Buy |
98
+6
| +7% | +$9 | ﹤0.01% | 6470 |
|
|
2023
Q1 | $175 | Buy |
92
+2
| +2% | +$4 | ﹤0.01% | 6485 |
|
|
2022
Q4 | $86 | Buy |
90
+2
| +2% | +$2 | ﹤0.01% | 6505 |
|
|
2022
Q3 | $0 | Buy |
88
+46
| +110% | – | ﹤0.01% | 6477 |
|
|
2022
Q2 | $0 | Buy |
42
+3
| +8% | – | ﹤0.01% | 6644 |
|
|
2022
Q1 | $0 | Buy |
39
+1
| +3% | – | ﹤0.01% | 6782 |
|
|
2021
Q4 | $0 | Hold |
38
| – | – | ﹤0.01% | 6767 |
|
|
2021
Q3 | $0 | Buy |
+38
| New | – | ﹤0.01% | 6714 |
|